Diagnostics Deals Market Analysis Partnering Terms & Agreements

1
Diagnostics Partnering Terms and Agreements
Published July 2014 No of Pages 2776 Single
User PDF US 3295 Corporate User PDF US
16495
2

Diagnostics Partnering Terms and Agreements
The report provides a detailed understanding and
analysis of how and why companies enter
diagnostic partnering deals. The majority of
deals are development stage whereby the licensee
obtains a right or an option right to license the
licensors diagnostic technology or product
candidates. These deals tend to be
multicomponent, starting with collaborative RD,
and commercialization of outcomes. Understanding
the flexibility of a prospective partners
negotiated deals terms provides critical insight
into the negotiation process in terms of what you
can expect to achieve during the negotiation of
terms. Whilst many smaller companies will be
seeking details of the payments clauses, the
devil is in the detail in terms of how payments
are triggered contract documents provide this
insight where press releases and databases do
not. The initial chapters of this report provide
an orientation of diagnostics dealmaking and
business activities. Chapter 1 provides an
introduction to the report, whilst chapter 2
provides an overview of the trends in diagnostics
dealmaking since 2009, including details of
average headline, upfront, milestone and royalty
terms and big pharma and big biotech
activities. Complete report available _at_
http//www.lifescienceindustryresearch.com/diagnos
tics-partnering-terms-and-agreements.html.
3

Diagnostics Partnering Terms and Agreements
Chapter 3 provides a review of the leading
diagnostics deals since 2009. Deals are listed by
headline value and signed by big pharm. Where the
deal has an agreement contract published at the
SEC a link provides online access to the
contract. Chapter 4 provides a comprehensive
listing of the top 50 big pharma companies that
have announced diagnsotic deals, with a brief
summary followed by a comprehensive listing of
diagnostics deals, as well as contract documents
available in the public domain. Where available,
each deal title links via Weblink to an online
version of the actual contract document,
providing easy access to each contract document
on demand. Chapter 5 provides a comprehensive
listing of the top 50 big biotech companies that
have announced diagnsotic deals, where diagnostic
deals are announced with a brief summary, as well
as contract documents available in the public
domain. Where available, each deal title links
via Weblink to an online version of the actual
contract document, providing easy access to each
contract document on demand. Order a copy of
this report at _at_ http//www.lifescienceindustryres
earch.com/purchase?rname16301.
4

Diagnostics Partnering Terms and Agreements
Chapter 6 provides a comprehensive and detailed
review of diagnostics partnering deals signed and
announced since January 2009, where a contract
document is available in the public domain. The
chapter is organized by cpmpany A-Z, stage of
development at signing, deal type (collaborative
RD, co-promotion, licensing etc), and specific
therapy focus. Each deal title links via Weblink
to an online version of the deal record and where
available, the contract document, providing easy
access to each contract document on
demand. Chapter 7 provides a comprehensive and
detailed review of diagnostics partnering deals
signed and announced since January 2009. The
chapter is organized by specific diagnostics
technology type in focus. Each deal title links
via Weblink to an online version of the deal
record and where available, the contract
document, providing easy access to each contract
document on demand. Report scope Diagnostics
Partnering Terms and Agreements is intended to
provide the reader with an in-depth understanding
of the diagnostic trends and structure of deals
entered into by leading companies
worldwide. Inquire for Discount _at_
http//www.lifescienceindustryresearch.com/purchas
e?rname16301.
5

Diagnostics Partnering Terms and Agreements
Diagnostics Partnering Terms and Agreements
provides the reader with the following key
benefits In-depth understanding of diagnostic
deal trends since 2009 Analysis of the structure
of diagnostic agreements with numerous real life
case studies Comprehensive access to over 3,700
diagnostic deals entered into by the worlds
biopharma companies Detailed access to actual
diagnostic contracts enter into by the leading
fifty big pharma and big biotech
companies Insight into the terms included in a
diagnostic agreement, together with real world
clause examples Understand the key deal terms
companies have agreed in previous deals Undertake
due diligence to assess suitability of your
proposed deal terms for partner
companies Inquire Before Buying _at_
http//www.lifescienceindustryresearch.com/inquire
-before-buying?rname16301
6
About us Life Science Industry
Research brings to you to the latest reports in
market research on Biotechnology, Diagnostics,
Healthcare, Medical Devices and Pharmaceuticals
segments from leading research publishers across
the globe. These reports also cover data and
information on sub-segments and sectors under
these life sciences categories.Contact us
(sales_at_lifescienceindustryresearch.com / 1 888
391 5441) for any of your research requirements
or topics of interest. Our sales research
associates will be happy to help you find
relevant market data.Website
www.lifescienceindustryresearch.com
Browse Latest Industry News, Updates, Trends,
Opportunities, Scenario all over the world _at_